IMGN Financial Facts
Net loss: -44.73MTotal operating expenses: 46.5M
See Full Income Statement
Accumulated deficit: -898.42M
Total current liabilities: 56.23M
See Full Balance Sheet
Immunogen Inc. (IMGN) Earnings
|
Expand Research on IMGN
Next EPS Date | 4/25/24 *Est. | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | +73.5% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +51.9% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
2/12/24 | Q423 | N/A | $0.13 | N/A | N/A | $129.48M | N/A | N/A | N/A | ||
2/9/24 | Q423 | N/A | $0.13 | N/A | N/A | $129.48M | N/A | N/A | N/A | ||
11/2/23 | Q323 | $0.10 | $0.04 | +$0.06 | $113.4M | $103.68M | N/A | Details | |||
2/25/22 | Q421 | -$0.17 | N/A | N/A | $28M | $85.8M | = | Details | |||
7/31/23 | Q223 | -$0.02 | -$0.13 | +$0.11 | $77.4M | $49.15M | N/A | Details | |||
1/30/15 | Q215 | $0.16 | -$0.05 | +$0.21 | $48.3M | $37.3M | N/A | Details | |||
2/12/21 | Q420 | $0.16 | -$0.10 | +$0.26 | $85.8M | $37.09M | = | Details | |||
11/3/17 | Q317 | -$0.61 | -$0.19 | -$0.42 | $8.5M | $33.62M | = | Details |